Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Business
Derek Rose

CSL injects $2.3b into US for valuable blood plasma

CSL has announced a multibillion-dollar investment in blood plasma production in the US. (Angela Brkic/AAP PHOTOS)

Australia's largest biotech company plans to expand its US presence with a $US1.5 billion ($A2.3 billion) investment that will allow it to manufacture more therapies derived from blood plasma collected in the states.

The funds injection could also potentially help CSL avoid or mitigate any future pharmaceutical tariffs imposed by US President Donald Trump.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.